This website uses cookies to enhance the user experience.
W

WAMALINO GROUP AS925 323 365

Purchase and sale
Limited company
Gjerdrums vei 8 0484 OSLO, Norge

WAMALINO GROUP AS

Keywords

pharmaceuticalshospital equipmentorthopedic articles

Organization

Chairman of the board
Years since formation
5 years
since Jul 9, 2020
Type
Limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
100,000
1 share class
Total number of shareholders
4
companies
Belongs to group of

Financials

Total operating income 2023
6,538,491
NOK
Annual total result 2023
-5,096,856
NOK
Total equity 2023
39,210,419
NOK
Last update: Aug 29, 2024

Management

Management / administration

NameRoleShares
Managing Director/CEO
12.08 %
indirectly

Board

NameRoleShares
DN
Board Member
13.9 %
indirectly
Board Member
12.08 %
indirectly
Chairman
16.5 %
indirectly

Others

NameRoleShares
M
MPR REVISJON AS
Auditor-
P
PROGRESSUM LØRENSKOG AS
Accountant-

Top 10 individual shareholders

NameRoleShares
-
33.5 %
indirectly
Chairman
16.5 %
indirectly
DN
Board Member
13.9 %
indirectly
Managing Director/CEO, Board Member
12.08 %
indirectly
-
6.04 %
indirectly
-
6.04 %
indirectly
-
2.32 %
indirectly
-
2.32 %
indirectly
-
2.32 %
indirectly
-
2.32 %
indirectly
Last update: Jul 26, 2024

Ownership

Company shareholders

NameShare classNumber of sharesShare
M
MARTINI INVEST AS
Ordinary shares
33,500
33.5 %
N
NICOMAX AS
Ordinary shares
26,840
26.84 %
D
DA-NO HOLDING AS
Ordinary shares
23,160
23.16 %
L
LINDBERG INVEST AS
Ordinary shares
16,500
16.5 %

Shares owned by the WAMALINO GROUP AS

NameShare classNumber of sharesShare
N
NORDIC MEDICAL GROUP AS
Ordinary shares
1,000
100 %
Ordinary shares
1,000
100 %
F
FBS GROUP AS
Ordinary shares
800
80 %
Last update: May 24, 2024

Group structure

  • Total operating income 2023: NOK 6,538,491
    Operating profit 2023: NOK -6,230,703
    Employees: 0

Financials

in NOK

Summary

Year202320222021
Total operating income
6,538,491
2,127,685
60,000
Annual Total Result
-5,096,856
-5,912,889
8,031,745
Total assets
94,114,359
85,854,238
83,489,586
Total liabilities
54,903,939
41,546,962
30,269,421
Total equity
39,210,419
44,307,276
53,220,164

P&L

Year202320222021
Total operating income
6,538,491
2,127,685
60,000
Total operating costs
12,769,194
9,564,824
2,892,609
Operating result
-6,230,703
-7,437,139
-2,832,609
Financial income/costs
1,133,847
1,524,251
10,864,353
Profit before tax
-5,096,856
-5,912,889
8,031,745
Total tax & extraordinary income/cost
0
0
0
Annual Total Result
-5,096,856
-5,912,889
8,031,745

Balance overview

Year202320222021
Total fixed assets
57,765,689
79,595,237
71,774,797
Total current assets
36,348,670
6,259,001
11,714,789
Total assets
94,114,359
85,854,238
83,489,586
Short term debt
47,247,238
30,546,962
15,263,851
Long term debt
7,656,701
11,000,000
15,005,570
Total liabilities
54,903,939
41,546,962
30,269,421
Contributed capital
40,100,000
40,100,000
40,100,000
Retained earnings
-889,581
4,207,276
13,120,164
Total equity
39,210,419
44,307,276
53,220,164
Total equity and liabilities
94,114,358
85,854,238
83,489,586

Classification

Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
G
Main industrial area
Wholesale and retail trade; repair of motor vehicles and motorcycles
46
Activity
Wholesale trade, except of motor vehicles and motorcycles
46.4
Main industrial group
Wholesale of household goods
46.46
Industrial group
Wholesale of pharmaceutical goods
46.460
Industrial group
Wholesale of pharmaceutical goods